Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Johnson & Johnson buy gerihouse

Start price
€54.70
07.01.13 / 50%
Target price
€62.00
21.02.13
Performance (%)
6.12%
End price
€58.05
21.02.13
Summary
This prediction ended on 21.02.13 with a price of €58.05. The BUY prediction by gerihouse finished with a performance of 6.12%. gerihouse has 50% into this prediction

Johnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.

Performance without dividends (%)
Name 1w 1m 1y 3y
Johnson & Johnson -2.434% -2.434% -8.843% 0.103%
iShares Core DAX® -0.992% -3.231% 11.661% 16.545%
iShares Nasdaq 100 -0.225% -3.339% 36.491% 43.334%
iShares Nikkei 225® -0.736% -7.859% 18.597% 4.253%
iShares S&P 500 -0.509% -2.979% 26.341% 40.911%

Comments by gerihouse for this prediction

In the thread Johnson & Johnson diskutieren
Prediction Buy
Perf. (%) 6.12%
Target price 62.000
Change
Ends at 21.02.13

Gute Perspektive

Die Deutsche Bank hat Johnson & Johnson von "Hold" auf "Buy" hochgestuft und das Kursziel von 75,00 auf 82,00 US-Dollar angehoben. Nachdem der Pharmakonzern in den vergangenen Jahren Herausforderungen unter anderem durch auslaufende Patenten sowie im Geschäft mit rezeptfreien Medikamenten durchgestanden habe, seien die Perspektiven für alle drei Sparten nun besser, schrieb Analystin Kristen Stewart in einer Studie vom Freitag. Das Unternehmen sei gut diversifiziert und positioniert. Die Expertin hält einen Bewertungsaufschlag im Vergleich zu den Aktien der Wettbewerber für angemessen.

Prediction Buy
Perf. (%) 6.12%
Target price 62.000
Change
Ends at 21.02.13

(Vom Mitglied beendet)

Stopped prediction by gerihouse for Johnson & Johnson

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€167.80
05.08.22
€190.00
05.08.23
-8.34%
06.08.23

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€142.86
08.07.21
€177.00
08.07.22
22.71%
08.07.22

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€127.70
09.09.20
€145.00
04.11.21
7.00%
12.02.21

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€116.60
28.08.19
€145.00
14.04.20
13.72%
14.04.20

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€116.04
18.07.17
€130.00
08.12.17
4.39%
08.12.17

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€113.94
19.04.17
€125.00
26.06.17
7.94%
26.06.17

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€83.27
21.09.15
€100.00
01.12.15
15.08%
01.12.15

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€87.67
09.12.14
€99.00
25.03.15
6.68%
25.03.15

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€80.57
10.10.14
€91.00
17.11.14
6.63%
17.11.14

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€72.48
22.04.14
€80.00
07.07.14
7.34%
07.07.14

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€52.61
16.10.12
€60.00
06.11.12
5.59%
06.11.12

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€51.73
14.06.12
€60.00
17.07.12
8.36%
17.07.12